FinTrust Capital Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $65.1K | Hold |
140
| – | – | 0.01% | 505 |
|
|
2024
Q2 | $65.6K | Buy |
140
+16
| +13% | +$7.5K | 0.01% | 471 |
|
|
2024
Q1 | $51.8K | Hold |
124
| – | – | 0.01% | 503 |
|
|
2023
Q4 | $50.5K | Buy |
124
+10
| +9% | +$4.07K | 0.01% | 479 |
|
|
2023
Q3 | $39.6K | Sell |
114
-160
| -58% | -$55.6K | 0.01% | 498 |
|
|
2023
Q2 | $79.1K | Hold |
274
| – | – | 0.02% | 380 |
|
|
2023
Q1 | $79.1K | Hold |
274
| – | – | 0.02% | 380 |
|
|
2022
Q4 | $79.1K | Sell |
274
-1,000
| -78% | -$289K | 0.02% | 380 |
|
|
2022
Q3 | $371K | Buy |
+1,274
| New | +$371K | 0.1% | 186 |
|
|
2021
Q3 | – | Sell |
-50
| Closed | -$10K | – | 1211 |
|
|
2021
Q2 | $10K | Sell |
50
-9
| -15% | -$1.8K | ﹤0.01% | 932 |
|
|
2021
Q1 | $13K | Hold |
59
| – | – | ﹤0.01% | 830 |
|
|
2020
Q4 | $14K | Sell |
59
-264
| -82% | -$62.6K | ﹤0.01% | 753 |
|
|
2020
Q3 | $88 | Buy |
323
+10
| +3% | +$3 | 0.02% | 381 |
|
|
2020
Q2 | $91K | Sell |
313
-24
| -7% | -$6.98K | 0.04% | 355 |
|
|
2020
Q1 | $80K | Buy |
337
+16
| +5% | +$3.8K | 0.04% | 327 |
|
|
2019
Q4 | $70K | Sell |
321
-27
| -8% | -$5.89K | 0.03% | 382 |
|
|
2019
Q3 | $59K | Hold |
348
| – | – | 0.02% | 395 |
|
|
2019
Q2 | $63K | Sell |
348
-24
| -6% | -$4.35K | 0.03% | 369 |
|
|
2019
Q1 | $68K | Sell |
372
-30
| -7% | -$5.48K | 0.03% | 337 |
|
|
2018
Q4 | $67K | Buy |
+402
| New | +$67K | 0.03% | 322 |
|